Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $584000.0.

  • Insight Molecular Diagnostics' Depreciation & Amortization (CF) rose 8364.78% to $584000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 7748.99%. This contributed to the annual value of $1.5 million for FY2024, which is 625.0% down from last year.
  • Insight Molecular Diagnostics' Depreciation & Amortization (CF) amounted to $584000.0 in Q3 2025, which was up 8364.78% from $559000.0 recorded in Q2 2025.
  • Insight Molecular Diagnostics' Depreciation & Amortization (CF)'s 5-year high stood at $584000.0 during Q3 2025, with a 5-year trough of $121000.0 in Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $384000.0 (2022), whereas its average is $367263.2.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Depreciation & Amortization (CF) soared by 26956.52% in 2021 and then crashed by 3044.44% in 2024.
  • Over the past 5 years, Insight Molecular Diagnostics' Depreciation & Amortization (CF) (Quarter) stood at $218000.0 in 2021, then skyrocketed by 83.49% to $400000.0 in 2022, then decreased by 25.0% to $300000.0 in 2023, then soared by 88.33% to $565000.0 in 2024, then increased by 3.36% to $584000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $584000.0 for Q3 2025, versus $559000.0 for Q2 2025 and $484000.0 for Q1 2025.